Rebecca Kondor

Rebecca Kondor

Auto-generated profile, based on publicly available information

Rebecca Kondor

Influenza Division, Centers for Disease Control and Prevention

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in eLife
Verified
Journal Article
Open access
JHJohn Huddleston
John Huddleston
JBJohn R Barnes
John R Barnes
TRThomas Rowe
Thomas Rowe
XXXiyan Xu
Xiyan Xu
RKRebecca Kondor
Rebecca Kondor
TBTrevor Bedford
Trevor Bedford
Seasonal influenza virus A/H3N2 is a major cause of death globally. Vaccination remains the most effective preventative. Rapid mutation of hemagglutinin allows viruses to escape adaptive immunity. This antigenic drift necessitates regular vaccine updates. Effective vaccine strains need to represent H3N2 populations circulating one year after strain selection. Experts select strains based on experimental measurements of antigenic drift and predictions made by models from hemagglutinin sequences. We developed a novel influenza forecasting framework that integrates phenotypic measures of antigenic drift and functional constraint with previously published sequence-only fitness estimates. Forecasts informed by phenotypic measures of antigenic drift consistently outperformed previous sequence-only estimates, while sequence-only estimates of functional constraint surpassed more comprehensive experimentally-informed estimates. Importantly, the best models integrated estimates of both functional constraint and either antigenic drift phenotypes or recent population growth.

25 September 2024 in eLife
Verified
Journal Article
Open access
APAmanda C Perofsky
Amanda C Perofsky
JHJohn Huddleston
John Huddleston
CHChelsea L Hansen
Chelsea L Hansen
JBJohn R Barnes
John R Barnes
TRThomas Rowe
Thomas Rowe
CVCécile Viboud
Cécile Viboud
Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here, we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997—2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection ynamics, presumably via heterosubtypic cross-immunity.

21 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KLKristine Lacek
Kristine Lacek
BRBenjamin L. Rambo-Martin
Benjamin L. Rambo-Martin
DBDhwani Batra
Dhwani Batra
XZXiao-Yu Zheng
Xiao-Yu Zheng
HSHitoshi Sakaguchi
Hitoshi Sakaguchi
CPClinton R. Paden
Clinton R. Paden
Recombination between SARS-CoV-2 virus variants can result in different viral properties (e.g., infectiousness or pathogenicity). In this report, we describe viruses with recombinant genomes containing signature mutations from Delta and Omicron variants. These genomes are the first evidence for a Delta-Omicron hybrid Spike protein in the United States.

1 October 2020 in Antiviral Research
Verified
Journal Article
Open access
MPMira C. Patel
Mira C. Patel
VMVasiliy P. Mishin
Vasiliy P. Mishin
JCJuan A. De La Cruz
Juan A. De La Cruz
ACAnton Chesnokov
Anton Chesnokov
HNHa T. Nguyen
Ha T. Nguyen
LGLarisa V. Gubareva
Larisa V. Gubareva
Baloxavir, a new antiviral drug targeting cap-dependent endonuclease activity of polymerase acidic (PA) protein of influenza viruses, is now approved in multiple countries. Several substitutions at isoleucine 38 in PA protein (e.g., PA-I38T) have been associated with decreased baloxavir susceptibility in vitro and in vivo. In recent years, next generation sequencing (NGS) analysis and pyrosequencing have been used by CDC and U.S. Public Health Laboratories to monitor drug susceptibility of influenza viruses. Here we described an improved pyrosequencing assay for detecting influenza A viruses carrying substitutions at PA-38. Cyclic and customized orders of nucleotide dispensation were evaluated, and pyrosequencing results were compared to those generated using NGS. Our data showed that the customized nucleotide dispensation has improved the pyrosequencing assay performance in identification of double mixtures (e.g., PA-38I/T); however, identification of PA-38 variants in triple mixtures remains a challenge. While NGS analysis indicated the presence of PA-I38K in one clinical specimen and isolate, our attempts to detect this mutation by pyrosequencing or recover the virus carrying PA-I38K in cell culture were unsuccessful, raising a possibility of a rarely occurring sequencing error. Overall, pyrosequencing provides a convenient means to detect baloxavir resistant influenza viruses when NGS is unavailable or a faster turnaround time is required.

12 January 2023 in Emerging Microbes & Infections
Verified
Journal Article
Open access
HXHongjie Xia
Hongjie Xia
JYJason Yeung
Jason Yeung
BKBirte Kalveram
Birte Kalveram
CBCody J. Bills
Cody J. Bills
JCJohn Yun-Chung Chen
John Yun-Chung Chen
PSPei-Yong Shi
Pei-Yong Shi
The rapid evolution of SARS-CoV-2 Omicron sublineages mandates a better understanding of viral replication and cross-neutralization among these sublineages. Here we used K18-hACE2 mice and primary human airway cultures to examine the viral fitness and antigenic relationship among Omicron sublineages. In both K18-hACE2 mice and human airway cultures, Omicron sublineages exhibited a replication order of BA.5 ≥ BA.2 ≥ BA.2.12.1 > BA.1; no difference in body weight loss was observed among different sublineage-infected mice. The BA.1-, BA.2-, BA.2.12.1-, and BA.5-infected mice developed distinguishable cross-neutralizations against Omicron sublineages, but exhibited little neutralization against the index virus (i.e. USA-WA1/2020) or the Delta variant. Surprisingly, the BA.5-infected mice developed higher neutralization activity against heterologous BA.2 and BA.2.12.1 than that against homologous BA.5; serum neutralizing titres did not always correlate with viral replication levels in infected animals. Our results revealed a distinct antigenic cartography of Omicron sublineages and support the bivalent vaccine approach.

23 June 2024 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
JCJessie R. Chung
Jessie R. Chung
PSPhilip Shirk
Philip Shirk
MGManjusha Gaglani
Manjusha Gaglani
MMManohar B. Mutnal
Manohar B. Mutnal
MNMary Patricia Nowalk
Mary Patricia Nowalk
BFBrendan Flannery
Brendan Flannery
Background: The 2022–23 US influenza season peaked early in fall 2022.Methods: Late‐season influenza vaccine effectiveness (VE) against outpatient, laboratory‐confirmed influenza was calculated among participants of the US Influenza VE Network using a test‐negative design.Results: Of 2561 participants enrolled from December 12, 2022 to April 30, 2023, 91 laboratory‐confirmed influenza cases primarily had A(H1N1)pdm09 (6B.1A.5a.2a.1) or A(H3N2) (3C.2a1b.2a.2b). Overall, VE was 30% (95% confidence interval −9%, 54%); low late‐season activity precluded estimation for most subgroups.Conclusions: 2022–23 late‐season outpatient influenza VE was not statistically significant. Genomic characterization may improve the identification of influenza viruses that circulate postinfluenza peak.